RHBC
ABMD

R.H. Bluestein & Co’s Abiomed Inc ABMD Stock Holding History

R.H. Bluestein & Co’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$252K Sell
1,025
-175
-15% -$47.3K 0.02% 274
2022
Q2 		$297K Hold
1,200
– – 0.02% 248
2022
Q1 		$397K Buy
1,200
+200
+20% +$61.6K 0.02% 238
2021
Q4 		$359K Hold
1,000
– – 0.01% 278
2021
Q3 		$326K Hold
1,000
– – 0.01% 301
2021
Q2 		$312K Hold
1,000
– – 0.01% 320
2021
Q1 		$319K Hold
1,000
– – 0.01% 295
2020
Q4 		$324K Sell
1,000
-300
-23% -$83K 0.01% 265
2020
Q3 		$360K Hold
1,300
– – 0.02% 207
2020
Q2 		$314K Buy
+1,300
New +$261K 0.02% 226
2020
Q1 		– Sell
-3,325
Closed -$567K – 366
2019
Q4 		$567K Buy
3,325
+425
+15% +$78.8K 0.03% 141
2019
Q3 		$516K Buy
2,900
+1,575
+119% +$340K 0.03% 148
2019
Q2 		$345K Sell
1,325
-437
-25% -$116K 0.02% 207
2019
Q1 		$503K Sell
1,762
-1,200
-41% -$399K 0.03% 136
2018
Q4 		$963K Sell
2,962
-816
-22% -$283K 0.08% 54
2018
Q3 		$1.7M Sell
3,778
-3,042
-45% -$1.2M 0.08% 56
2018
Q2 		$2.79M Sell
6,820
-11,575
-63% -$4.19M 0.14% 46
2018
Q1 		$5.35M Buy
18,395
+13,995
+318% +$3.55M 0.29% 47
2017
Q4 		$825K Sell
4,400
-19,200
-81% -$3.58M 0.04% 96
2017
Q3 		$3.98M Buy
23,600
+20,750
+728% +$3.14M 0.22% 51
2017
Q2 		$408K Buy
2,850
+200
+8% +$26.9K 0.02% 167
2017
Q1 		$332K Buy
+2,650
New +$307K 0.02% 221

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

R.H. Bluestein & Co's ABMD Position: Q3 2022 in Review

R.H. Bluestein & Co reduced its Abiomed Inc (ABMD) stake by 15% in Q3 2022, selling an estimated $47.3K and leaving 1,025 shares worth $252K. The position accounts for 0.02% of the portfolio, ranked #274.

R.H. Bluestein & Co first reported a position in ABMD in Q1 2017 and has held it in 22 quarters since. The position peaked at $5.35M in Q1 2018. 517 funds tracked by Wall St. Rank hold ABMD as of Q3 2022.

  • R.H. Bluestein & Co held 1,025 shares of Abiomed Inc worth $252K as of Q3 2022.
  • R.H. Bluestein & Co sold 175 Abiomed Inc shares in Q3 2022, an estimated $47.3K.
  • Abiomed Inc made up 0.02% of R.H. Bluestein & Co's portfolio in Q3 2022, its #274 holding.
  • R.H. Bluestein & Co first reported a position in Abiomed Inc in Q1 2017 and has held it in 22 quarters since.
  • R.H. Bluestein & Co's Abiomed Inc position peaked at $5.35M in Q1 2018.
  • 517 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2022.

Based on R.H. Bluestein & Co's 13F filing for Q3 2022, filed 14 Nov 2022.